Pharmaceutical

Asieris showcases Phase III win in treating precancerous cervical lesions

Asieris presented positive Phase III results at the 2024 Society of Gynecologic Oncology (SGO) Annual Meeting in San Diego, US.

Mar 20, 2024 - 00:00
Asieris showcases Phase III win in treating precancerous cervical lesions
Asieris presented positive Phase III results at the 2024 Society of Gynecologic Oncology (SGO) Annual Meeting in San Diego, US.
Read the original article

Tags:

Previous Article

Eli Lilly’s partnership with Amazon to boost presence in diabetes and obesity ma...

Next Article

AstraZeneca to acquire radioconjugate biotech Fusion in $2.4bn deal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AstronauTx wins £48m in funding for developing Alzheimer’s therapies

AstronauTx wins £48m in funding for developing Alzheime...

Oct 9, 2023

Opinion: The end of affirmative action means it’s time to revise pre-med requirements

Opinion: The end of affirmative action means it’s time ...

Nov 11, 2023

After ‘SNL’ skit on sickle cell CRISPR therapy, advocates cite errors and stereotypes

After ‘SNL’ skit on sickle cell CRISPR therapy, advocat...

Dec 21, 2023